Year archive

NexgenRx Inc. — 2023 filings

All 20 regulatory filings released by NexgenRx Inc. (NXG) in 2023, sourced directly from the official regulator.

20 Filings

2023 Period

2023 filings (20)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2023-12-29	English
News release - English.pdf Regulatory Filings	2023-12-21	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2023-08-31	English
News release - English.pdf Regulatory Filings	2023-08-21	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-08-21	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-08-21	English
Interim MD&A - English.pdf Regulatory Filings	2023-08-21	English
Interim financial statements/report – English.pdf Regulatory Filings	2023-08-21	English
News release - English.pdf Regulatory Filings	2023-05-19	English
Interim MD&A - English.pdf Regulatory Filings	2023-05-18	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-05-18	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-05-18	English
Interim financial statements/report – English.pdf Regulatory Filings	2023-05-18	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2023-04-11	English
News release - English.pdf Regulatory Filings	2023-04-07	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2023-04-07	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2023-04-07	English
Annual MD&A - English.pdf Regulatory Filings	2023-04-07	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2023-04-07	English
Audited annual financial statements – English.PDF Regulatory Filings	2023-04-07	English